Interpace Biosciences Inc
OTC:IDXG
Income Statement
Earnings Waterfall
Interpace Biosciences Inc
Revenue
|
38.2m
USD
|
Cost of Revenue
|
-15.4m
USD
|
Gross Profit
|
22.8m
USD
|
Operating Expenses
|
-21.2m
USD
|
Operating Income
|
1.6m
USD
|
Other Expenses
|
-3.2m
USD
|
Net Income
|
-1.6m
USD
|
Income Statement
Interpace Biosciences Inc
Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
150
N/A
|
147
-2%
|
135
-8%
|
129
-5%
|
123
-5%
|
2
-99%
|
8
+433%
|
(21)
N/A
|
(47)
-125%
|
9
N/A
|
(26)
N/A
|
(25)
+5%
|
(24)
+3%
|
13
N/A
|
14
+3%
|
14
+2%
|
15
+7%
|
16
+8%
|
17
+9%
|
19
+9%
|
21
+8%
|
22
+7%
|
23
+5%
|
24
+3%
|
26
+8%
|
24
-6%
|
27
+13%
|
26
-3%
|
27
+2%
|
32
+20%
|
33
+2%
|
34
+2%
|
34
0%
|
33
-1%
|
31
-6%
|
33
+4%
|
33
+0%
|
32
-2%
|
34
+6%
|
37
+11%
|
38
+2%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(123)
|
(123)
|
(115)
|
(111)
|
(106)
|
(1)
|
(5)
|
19
|
41
|
(7)
|
23
|
23
|
23
|
(7)
|
(7)
|
(7)
|
(8)
|
(7)
|
(8)
|
(9)
|
(9)
|
(10)
|
(10)
|
(11)
|
(13)
|
(16)
|
(19)
|
(20)
|
(21)
|
(22)
|
(21)
|
(18)
|
(17)
|
(14)
|
(12)
|
(15)
|
(15)
|
(14)
|
(14)
|
(15)
|
(15)
|
|
Gross Profit |
27
N/A
|
24
-13%
|
20
-14%
|
19
-8%
|
18
-4%
|
0
-99%
|
3
+1 250%
|
(2)
N/A
|
(5)
-152%
|
3
N/A
|
(3)
N/A
|
(2)
+44%
|
(1)
+44%
|
6
N/A
|
6
-2%
|
7
+3%
|
7
+9%
|
9
+20%
|
9
+6%
|
10
+14%
|
11
+9%
|
12
+4%
|
13
+10%
|
13
-1%
|
13
-1%
|
8
-35%
|
8
-6%
|
6
-21%
|
6
+3%
|
11
+67%
|
12
+15%
|
16
+26%
|
17
+8%
|
19
+12%
|
19
+1%
|
18
-5%
|
18
+2%
|
18
N/A
|
20
+7%
|
23
+15%
|
23
+1%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(52)
|
(25)
|
(24)
|
(23)
|
(23)
|
(16)
|
(23)
|
(25)
|
(25)
|
(25)
|
(38)
|
(35)
|
(32)
|
(10)
|
(2)
|
(3)
|
(3)
|
(15)
|
(22)
|
(22)
|
(22)
|
(24)
|
(26)
|
(28)
|
(32)
|
(32)
|
(38)
|
(37)
|
(36)
|
(37)
|
(35)
|
(32)
|
(29)
|
(24)
|
(23)
|
(24)
|
(23)
|
(22)
|
(22)
|
(22)
|
(21)
|
|
Selling, General & Administrative |
(27)
|
(25)
|
(24)
|
(23)
|
(23)
|
(15)
|
(19)
|
(19)
|
(18)
|
(27)
|
(22)
|
(19)
|
(18)
|
(16)
|
(14)
|
(15)
|
(15)
|
(16)
|
(17)
|
(17)
|
(17)
|
(17)
|
(18)
|
(20)
|
(23)
|
(26)
|
(28)
|
(28)
|
(28)
|
(30)
|
(28)
|
(27)
|
(24)
|
(20)
|
(20)
|
(21)
|
(21)
|
(20)
|
(20)
|
(20)
|
(19)
|
|
Research & Development |
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(2)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
(4)
|
(4)
|
(4)
|
(3)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
Other Operating Expenses |
(24)
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
(2)
|
8
|
(9)
|
(9)
|
(8)
|
12
|
18
|
18
|
17
|
6
|
(0)
|
(0)
|
(0)
|
(2)
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
Operating Income |
(25)
N/A
|
(1)
+94%
|
(4)
-193%
|
(4)
-7%
|
(6)
-25%
|
(16)
-185%
|
(20)
-29%
|
(27)
-33%
|
(30)
-13%
|
(23)
+25%
|
(41)
-81%
|
(37)
+12%
|
(33)
+10%
|
(3)
+91%
|
4
N/A
|
4
-16%
|
4
N/A
|
(6)
N/A
|
(13)
-110%
|
(12)
+13%
|
(11)
+5%
|
(13)
-16%
|
(13)
N/A
|
(15)
-17%
|
(19)
-26%
|
(24)
-29%
|
(30)
-24%
|
(30)
-2%
|
(29)
+4%
|
(26)
+10%
|
(22)
+15%
|
(17)
+26%
|
(12)
+27%
|
(5)
+55%
|
(4)
+35%
|
(6)
-74%
|
(5)
+20%
|
(4)
+27%
|
(2)
+47%
|
1
N/A
|
2
+100%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(2)
|
(3)
|
(4)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(1)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(18)
|
0
|
0
|
(3)
|
(3)
|
(5)
|
(8)
|
(4)
|
(4)
|
(3)
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(3)
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(2)
|
(2)
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
|
Pre-Tax Income |
(25)
N/A
|
(2)
+94%
|
(4)
-173%
|
(4)
-5%
|
(6)
-28%
|
(19)
-236%
|
(22)
-18%
|
(30)
-35%
|
(34)
-15%
|
(44)
-30%
|
(44)
0%
|
(39)
+11%
|
(39)
+2%
|
(9)
+78%
|
(3)
+70%
|
(6)
-112%
|
(2)
+65%
|
(13)
-589%
|
(18)
-38%
|
(13)
+26%
|
(13)
+3%
|
(13)
+2%
|
(13)
-2%
|
(16)
-27%
|
(21)
-27%
|
(27)
-28%
|
(30)
-12%
|
(30)
0%
|
(29)
+4%
|
(26)
+9%
|
(24)
+8%
|
(18)
+24%
|
(14)
+23%
|
(8)
+45%
|
(5)
+39%
|
(7)
-49%
|
(6)
+10%
|
(6)
+8%
|
(4)
+24%
|
(2)
+57%
|
(1)
+42%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
5
|
5
|
5
|
6
|
13
|
13
|
13
|
13
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(25)
|
(2)
|
(4)
|
(5)
|
(6)
|
(14)
|
(17)
|
(24)
|
(28)
|
(31)
|
(31)
|
(26)
|
(26)
|
(8)
|
(3)
|
(5)
|
(2)
|
(13)
|
(18)
|
(13)
|
(13)
|
(14)
|
(14)
|
(17)
|
(22)
|
(28)
|
(31)
|
(31)
|
(30)
|
(27)
|
(25)
|
(19)
|
(14)
|
(7)
|
(4)
|
(6)
|
(6)
|
(6)
|
(4)
|
(2)
|
(1)
|
|
Net Income (Common) |
(25)
N/A
|
(5)
+81%
|
(8)
-80%
|
(10)
-22%
|
(12)
-22%
|
(16)
-31%
|
(18)
-14%
|
(23)
-23%
|
(23)
-3%
|
(11)
+51%
|
(12)
-8%
|
(8)
+38%
|
(10)
-34%
|
(8)
+19%
|
(1)
+87%
|
(5)
-364%
|
(1)
+82%
|
(12)
-1 256%
|
(18)
-46%
|
(13)
+25%
|
(13)
+2%
|
(13)
+3%
|
(13)
-1%
|
(16)
-27%
|
(21)
-28%
|
(27)
-31%
|
(33)
-23%
|
(34)
-1%
|
(32)
+4%
|
(30)
+9%
|
(24)
+18%
|
(22)
+9%
|
(19)
+12%
|
(15)
+23%
|
(13)
+13%
|
(13)
-4%
|
(24)
-79%
|
(22)
+8%
|
(19)
+12%
|
(15)
+21%
|
(2)
+89%
|
|
EPS (Diluted) |
-246.99
N/A
|
-45.99
+81%
|
-83
-80%
|
-100.99
-22%
|
-123
-22%
|
-161
-31%
|
-91.99
+43%
|
-113.49
-23%
|
-116.5
-3%
|
-57
+51%
|
-61.5
-8%
|
-37.99
+38%
|
-51
-34%
|
-41.5
+19%
|
-2.75
+93%
|
-5.09
-85%
|
-0.4
+92%
|
-7.62
-1 805%
|
-6.35
+17%
|
-4.78
+25%
|
-4.67
+2%
|
-4.53
+3%
|
-3.65
+19%
|
-4.26
-17%
|
-5.44
-28%
|
-7.35
-35%
|
-8.35
-14%
|
-8.21
+2%
|
-8.1
+1%
|
-7.37
+9%
|
-5.87
+20%
|
-5.21
+11%
|
-4.59
+12%
|
-3.63
+21%
|
-3.07
+15%
|
-3.11
-1%
|
-5.71
-84%
|
-5.23
+8%
|
-4.48
+14%
|
-3.53
+21%
|
-0.37
+90%
|